Fotini B. Karassa
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research 11
- Rheumatoid Arthritis Research and Therapies 3
- Immunology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 6
- Neurology top 10%
- Peripheral Neuropathies and Disorders 4
- Nephrology top 10%
-
- Systemic Sclerosis and Related Diseases 5
-
- Meta-analysis and systematic reviews 4
-
- Glycosylation and Glycoproteins Research 3
-
- Vasculitis and related conditions 3
Fotini B. Karassa
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 85
- Rheumatology 825
- Immunology 448
- Radiology, Nuclear Medicine and Imaging 308
- Neurology 174
- Nephrology 63
Countries citing papers authored by Fotini B. Karassa
This map shows the geographic impact of Fotini B. Karassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fotini B. Karassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fotini B. Karassa more than expected).
Fields of papers citing papers by Fotini B. Karassa
This network shows the impact of papers produced by Fotini B. Karassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fotini B. Karassa. The network helps show where Fotini B. Karassa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fotini B. Karassa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2022 | 1 | |
| 3 | 2020 | 4 | |
| 4 | 2015 | 4 | |
| 5 | 2013 | 37 | |
| 6 | 2013 | 2 | |
| 7 | 2010 | 57 | |
| 8 | Mortality in systemic sclerosis. | 2009 | 28 |
| 9 | 2005 | 165 | |
| 10 | 2005 | 258 | |
| 11 | 2004 | 46 | |
| 12 | 2003 | 35 | |
| 13 | 2003 | 103 | |
| 14 | 2002 | 153 | |
| 15 | 2002 | 41 | |
| 16 | Bias in uncontrolled therapeutic trials in rheumatology due to selection of populations with extreme characteristics. | 2001 | 9 |
| 17 | 2000 | 71 | |
| 18 | 2000 | 80 | |
| 19 | 1999 | 4 | |
| 20 | 1993 | 75 |
About Fotini B. Karassa
Fotini B. Karassa is a scholar working on Rheumatology, Statistics, Probability and Uncertainty and Pathology and Forensic Medicine, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Systemic Sclerosis and Related Diseases (5 papers), Peripheral Neuropathies and Disorders (4 papers), Meta-analysis and systematic reviews (4 papers), Glycosylation and Glycoproteins Research (3 papers), Vasculitis and related conditions (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). The work is most often cited by research in Rheumatology (825 citations), Immunology (448 citations) and Radiology, Nuclear Medicine and Imaging (308 citations). Fotini B. Karassa has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include John P. A. Ioannidis, Thomas A Trikalinos, Wolfgang Schmidt, Miltiadis I. Matsagas, for the RED-CABG Steering Committee and Investigators, Haralampos Μ. Moutsopoulos, Alexandros A. Drosos, Kyriaki Boki, Giota Touloumi and Maria I. Argyropoulou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.